Skip to Content

Notice

Scientific Considerations Related to Developing Follow-On Protein Products; Correction

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice of public workshop; correction.

SUMMARY:

The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of August 16, 2004 (69 FR 50386). The document announced a public workshop on scientific and technical considerations related to the development of follow-on protein pharmaceutical products. The document was published with an inadvertent error. This document corrects that error.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Joyce Strong, Office of Policy (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010.

End Further Info

In FR Doc. 04-18627 appearing on page 50386 in the issue of August 16, 2004, the following correction is made: On page 50386, in the third column, under the heading ADDRESSES, in the second paragraph add a new second sentence to read: Submit electronic comments to http://www.fda.gov/​dockets/​ecomments.

Start Signature

Dated: August 31, 2004.

William K. Hubbard,

Associate Commissioner for Policy and Planning.

End Signature End Preamble

[FR Doc. 04-20289 Filed 9-1-04; 4:34 pm]

BILLING CODE 4160-01-S